A High Resolution Mass Spectrometry Study Reveals the Potential of Disulfide Formation in Human Mitochondrial Voltage-Dependent Anion Selective Channel Isoforms (hVDACs).


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
21 Feb 2020
Historique:
received: 19 12 2019
revised: 13 02 2020
accepted: 18 02 2020
entrez: 27 2 2020
pubmed: 27 2 2020
medline: 20 11 2020
Statut: epublish

Résumé

The voltage-dependent anion-selective channels (VDACs), which are also known as eukaryotic porins, are pore-forming proteins, which allow for the passage of ions and small molecules across the outer mitochondrial membrane (OMM). They are involved in complex interactions that regulate organelle and cellular metabolism. We have recently reported the post-translational modifications (PTMs) of the three VDAC isoforms purified from rat liver mitochondria (rVDACs), showing, for the first time, the over-oxidation of the cysteine residues as an exclusive feature of VDACs. Noteworthy, this peculiar PTM is not detectable in other integral membrane mitochondrial proteins, as defined by their elution at low salt concentration by a hydroxyapatite column. In this study, the association of tryptic and chymotryptic proteolysis with UHPLC/High Resolution nESI-MS/MS, allowed for us to extend the investigation to the human VDACs. The over-oxidation of the cysteine residues, essentially irreversible in cell conditions, was as also certained in VDAC isoforms from human cells. In human VDAC2 and 3 isoforms the permanently reduced state of a cluster of close cysteines indicates the possibility that disulfide bridges are formed in the proteins. Importantly, the detailed oxidative PTMs that are found in human VDACs confirm and sustain our previous findings in rat tissues, claiming for a predictable characterization that has to be conveyed in the functional role of VDAC proteins within the cell. Data are available via ProteomeXchange with identifier PXD017482.

Identifiants

pubmed: 32098132
pii: ijms21041468
doi: 10.3390/ijms21041468
pmc: PMC7073118
pii:
doi:

Substances chimiques

Disulfides 0
Mitochondrial Membrane Transport Proteins 0
Protein Isoforms 0
VDAC2 protein, human 0
VDAC3 protein, human 0
Voltage-Dependent Anion Channel 2 0
Voltage-Dependent Anion Channels 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Curr Med Chem. 2017;24(40):4447-4469
pubmed: 28554318
Free Radic Res. 2006 Dec;40(12):1250-8
pubmed: 17090414
Antioxid Redox Signal. 2003 Oct;5(5):577-82
pubmed: 14580313
J Biol Chem. 2008 May 9;283(19):13482-90
pubmed: 18308720
Biosci Rep. 2009 Jul 22;29(6):351-62
pubmed: 18976238
Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15370-5
pubmed: 18832158
J Gen Physiol. 2019 Apr 1;151(4):489-504
pubmed: 30674561
Biochim Biophys Acta Biomembr. 2017 Mar;1859(3):301-311
pubmed: 27989743
Oncotarget. 2016 Jan 19;7(3):2249-68
pubmed: 26760765
Nucleic Acids Res. 2013 Jan;41(Database issue):D1063-9
pubmed: 23203882
Cell Death Differ. 2005 Jul;12(7):751-60
pubmed: 15818409
Sci Rep. 2016 Oct 10;6:34802
pubmed: 27721436
Antioxid Redox Signal. 2010 Aug 15;13(4):539-49
pubmed: 19958171
Mol Cell Biochem. 2002 May-Jun;234-235(1-2):3-9
pubmed: 12162447
Cell Signal. 2013 Dec;25(12):2685-92
pubmed: 24018046
J Biol Chem. 1993 Jan 25;268(3):1835-41
pubmed: 8420959
Chem Rev. 2013 Jan 9;113(1):596-698
pubmed: 23181411
EMBO J. 1987 Sep;6(9):2627-33
pubmed: 2960519
Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15036-40
pubmed: 8986759
Biochim Biophys Acta Bioenerg. 2018 Sep;1859(9):806-816
pubmed: 29890122
Science. 2008 Aug 29;321(5893):1206-10
pubmed: 18755977
J Am Soc Mass Spectrom. 2003 Jun;14(6):605-13
pubmed: 12781462
J Biol Chem. 1992 Oct 15;267(29):21072-9
pubmed: 1328220
FEBS Lett. 1996 Apr 8;384(1):9-13
pubmed: 8797793
Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17742-7
pubmed: 18988731
Biochim Biophys Acta. 2012 Jun;1818(6):1466-76
pubmed: 22020053
Biochem J. 2010 Jul 1;429(1):147-55
pubmed: 20420578

Auteurs

Maria G G Pittalà (MGG)

Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia 64, 95123 Catania, Italy.

Rosaria Saletti (R)

Department of Chemical Sciences, Organic Mass Spectrometry Laboratory, University of Catania, Viale A. Doria 6, 95125 Catania, Italy.

Simona Reina (S)

Department of Biological, Geological and Environmental Sciences, Section of Molecular Biology, University of Catania, Viale A. Doria 6, 95125 Catania, Italy.

Vincenzo Cunsolo (V)

Department of Chemical Sciences, Organic Mass Spectrometry Laboratory, University of Catania, Viale A. Doria 6, 95125 Catania, Italy.

Vito De Pinto (V)

Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia 64, 95123 Catania, Italy.

Salvatore Foti (S)

Department of Chemical Sciences, Organic Mass Spectrometry Laboratory, University of Catania, Viale A. Doria 6, 95125 Catania, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH